Goto

Collaborating Authors

 atlantis


The real Atlantis? Scientists discover lost islands that sank off the coast of the Canary Islands millions of years ago - and claim they could have been the inspiration for the famous legend

Daily Mail - Science & tech

Atlantis is the world's most famous fictional island, invented by Greek philosopher Plato 2,300 years ago. But Spanish researchers claim to have found the source of his inspiration – a series of sunken islands off the northwest coast of Africa. The former islands would have been close to the modern-day Canary Islands, but they sunk millions of years ago, the experts think. They've christened the now-submerged lands'Los Atlantes', in reference to the myth of Atlantis which still persists today. Luis Somoza, a marine geologist at Geological Survey of Spain (IGME-CSIC), told Live Science: 'This could be the origin of the Atlantis legend.'


Generating a full-length work of fiction with GPT-4

#artificialintelligence

The goal of this project was to have the GPT-4 version of ChatGPT, the latest instructional large language model, generate an entire novel from scratch, including the title, genre, story, characters, settings, and all the writing, with no human input. It is impossible currently to do this using a single prompt ("write me a book"), but what is possible is to supply a series of prompts that give structure to the process and allow it to complete this large task, one step at a time. However, in order to ensure that all the creative work is done by GPT-4, prompts are not allowed to make specific references to the content of the book, only the book's structure. The intention is that the process should be simple, mechanical and possible (in principle) to fully automate. Each time the process is repeated from the beginning, it should create another entirely new book, based solely on GPT-4's independent creative choices.


This week in games: Katamari Damacy finally rolls onto PCs, Tencent's snowboarding battle royale

PCWorld

With the amount of news out of Japan this week, you'd think Tokyo Game Show had already started. That didn't stop a flood of trailers though, including new footage of Sekiro: Shadows Die Twice and Project Judge, a new game from the Yakuza devs. Other than that, an avalanche of weirdness this week: Alan Wake's headed to TV, Pathologic 2 showed off its creepy village, Katamari Damacy's coming to PC, Assassin's Creed III is getting a remaster (for some reason), and Tencent brought a literal avalanche with its snowboarding battle royale game Ring of Elysium. This is gaming news for September 10 to 14. Much to my surprise, Focus's Call of Cthulhu is one of my most anticipated games in the back half of 2018.


Patient Insights in the Age of AI

#artificialintelligence

"One of the greatest cost drivers in healthcare is still hiding in plain sight. So began an article in Forbes last month by Hayden Bosworth, professor of medicine, psychiatry, and nursing at Duke University Medical Center, and Prescriptions for a Healthy America's Sloane Salzburg. The authors called for the issue to be a made "a national priority," and reported on the recommendations by a group of experts representing patients, physicians, pharmacies, and pharma companies on how to fix the problem. Bosworth and Sloane identified the need for improved information sharing between the clinical and pharmacy setting, better integration of healthcare systems, the leveraging of new and better technologies, and better incentives for healthcare providers, plans and drug manufacturers to improve patient adherence in federal healthcare programs. It is revealing that this call for action positions new and better technology as only part of the solution. In the field of digital health and patient adherence, one could be forgiven for thinking that the answers to the nonadherence problem lie in the advancing connectivity protocols and mobile solutions that incorporate medication reminders and encouragement, or enable the timing of medication access to be controlled. In the last few years, as Dr. Bill Byrom, senior director, product innovation, for the contract research organization ICON, points out, we have seen the emergence of: Such innovations continue apace, and their contribution to tackling nonadherence is vital. However, Bosworth reminds us that, while digital health is "definitely here, it's just part of the toolbox." He told Pharm Exec: "If people think of it as panacea that is going to solve everything, they will be consistently disappointed." Clare Moloney, Atlantis Healthcare's clinical strategy director, Europe, further explains: "There is still the thinking that if you put something in an app or on someone's phone, or if you put a device in someone's home, that it is going to be a magic fix.